Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin on Platelet Reactivity in CAD Patients on DAPT
NCT02030054Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary artery disease (CAD) comparing Atorvastatin Sequence with Rosuvastatin Sequence (2 arms). Primary endpoint: P2Y12 Reaction Units at 30 days. Status: unknown.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02030054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030054.